Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2022-05-13 Earnings Release
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
RaySearch releases preliminary resultat for the first quarter of 2022
Earnings Release Classification · 99% confidence The document is titled 'PRESS RELEASE' and explicitly states 'RaySearch releases preliminary resultat for the first quarter of 2022'. It provides key financial highlights (Order intake, net sales, EBIT) for the first quarter (Q1) of 2022. This format—a brief press release announcing preliminary period results—aligns perfectly with the definition of an Earnings Release (ER), which covers initial announcements of periodical financial results (key highlights only). It is not the comprehensive Interim Report (IR) nor the Annual Report (10-K). The document length (2544 chars) is short, but it contains the results themselves, not just an announcement that a report is available, thus ER is the most appropriate classification over RPA/RNS. Q1 2022
2022-05-13 English
Correction of press release: Missing MAR label in previous press release “RaySearch collaborates with GE Healthcare to improve radiation oncology treatment planning”
Regulatory Filings Classification · 95% confidence The document is explicitly titled '# PRESS RELEASE' and details a collaboration agreement between RaySearch Laboratories and GE Healthcare. Crucially, it contains the mandatory disclosure statement required by the EU Market Abuse Regulation (MAR): 'This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.' This structure—a press release announcing material business information that is subject to MAR disclosure—is characteristic of a general regulatory announcement, often categorized as an Earnings Release (ER) if it contained financial results, or a general Regulatory Filing (RNS) if it is a significant, non-financial operational update. Since this is a collaboration announcement and not a formal financial report (like 10-K or IR) or a specific management/dividend announcement, the most appropriate general category for mandatory regulatory disclosures that don't fit elsewhere is RNS (Regulatory Filings). The document length (7103 chars) is substantial enough that it is the primary document, not just an announcement of a document (RPA).
2022-05-09 English
Rättelse: Saknad MAR-etikett i tidigare pressmeddelande ”RaySearch samarbetar med GE Healthcare för att förbättra dosplanering vid strålningsbehandling av cancer”
Regulatory Filings Classification · 95% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and announces a collaboration between RaySearch Laboratories and GE Healthcare. Crucially, it contains specific regulatory language: "Denna information är sådan information som RaySearch Laboratories AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning (MAR)." (This information is information that RaySearch Laboratories AB (publ) is obliged to disclose pursuant to the EU's Market Abuse Regulation (MAR)). This indicates it is a mandatory regulatory disclosure concerning material business information, not a periodic financial report (like 10-K or IR) or a general announcement of a report (RPA). Since it is a press release disclosing material, non-financial business information that falls under MAR disclosure requirements, and it doesn't fit specific categories like DIRS, DIV, or CAP, the most appropriate general regulatory filing category is RNS (Regulatory Filings), which serves as the fallback for miscellaneous regulatory announcements not covered elsewhere. Furthermore, the document is a correction to a previous press release, confirming its nature as an immediate regulatory announcement.
2022-05-09 Swedish
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a navigation page for the Swedish Financial Supervisory Authority (Finansinspektionen) portal for stock market information. It contains links for searching, reporting, and flagging, but does not contain any specific financial data, corporate reports, or regulatory announcements. As it is a general portal interface and does not fit into any specific category, it is classified as a general regulatory filing.
2022-04-29 English
Annual Report 2021
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2021' which translates to 'Annual Report 2021' in Swedish. It contains detailed sections typical of an annual report such as business overview, CEO comments, market and competitors, products, sustainability report, auditor's statement, management report, risk management, consolidated and parent company financial statements, notes, audit report, corporate governance report, board and management information, share and ownership information, and financial calendar. The length is substantial (15,000 characters) and includes comprehensive financial and operational data for the full fiscal year 2021. This matches the definition of an Annual Report (10-K) which covers company activity and full financial performance for the year. There is no indication that this is merely an announcement or a presentation, nor is it a quarterly or interim report. Therefore, the correct classification is Annual Report (10-K). FY 2021
2022-04-29 Swedish
Annual Report 2021
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2021' which translates to 'Annual Report 2021' in Swedish. It contains detailed sections typical of an annual report such as business overview, CEO comments, market and competitors, products, sustainability report, auditor's statement, management report, risk management, financial statements, notes, audit report, corporate governance report, board and management information, shareholding information, and financial calendar. The document length is substantial (15,000 characters) and includes comprehensive financial and operational data for the full fiscal year 2021. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2022-04-29 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.